Abstract
Background: Prospective pain genetics research is hindered by a lack of data on the prevalence of polymorphisms in pain-relevant genes for patients with sickle cell disease (SCD). For African-Americans in general, limited information is available in public databases. Methods: We prioritized and examined the genotype and allele frequencies of 115 SNPs from 49 candidate pain genes in 199 adult African-Americans and pediatric patients of African origin with SCD. Analyses were performed and compared with available data from public databases. Results: Genotype and allele frequencies of a number of SNPs were found to be different between our cohort and those from the databases and between adult and pediatric subjects. Conclusion: As pain therapy is inadequate in a significant percentage of patients with SCD, candidate pain genetic studies may aid in designing precision pain medicine. We provide prevalence data as a reference for prospective genetic studies in this population.
Original language | English |
---|---|
Pages (from-to) | 1795-1806 |
Number of pages | 12 |
Journal | Pharmacogenomics |
Volume | 16 |
Issue number | 16 |
DOIs | |
State | Published - Nov 2015 |
Externally published | Yes |
Keywords
- African-American
- genotype
- pain
- pharmacogenomics
- polymorphisms
- population
- sickle cell disease
- SNPs